(c) 2024 PillSync.com

Trientine hydrochloride 250 MG Oral Capsule

INDICATIONS AND USAGE Trientine HCl capsules are indicated in the treatment of patients with Wilson’s disease who are intolerant of penicillamine. Clinical experience with trientine HCl capsules is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient’s dose have not been well defined. Trientine HCl capsules and penicillamine cannot be considered interchangeable. Trientine HCl capsules should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. Unlike penicillamine, trientine HCl capsules are not recommended in cystinuria or rheumatoid arthritis. The absence of a sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. In 15 patients with rheumatoid arthritis, trientine HCl capsules was reported not to be effective in improving any clinical or biochemical parameter after 12 weeks of treatment. Trientine HCl capsules are not indicated for treatment of biliary cirrhosis.

Amneal Pharmaceuticals NY LLC


4 years ago CAPSULE BROWN TRIENTINE 250mg Trientine hydrochloride 250 MG Oral Capsule

CAPSULE BROWN TRIENTINE 250mg

HOW SUPPLIED Trientine HCl capsules, USP, 250 mg , are supplied as hard gelatin caramel colored capsules printed with black ink: “TRIENTINE” on cap and “250 mg” on body. They are available as follows: Bottles of 100: NDC 69238-1545-1


More pills like CAPSULE TRIENTINE 250mg












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site